Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-11-000472
Filing Date
2011-02-10
Accepted
2011-02-10 16:58:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 c210110sc13g.htm SC 13G 74715
  Complete submission text file 0001214659-11-000472.txt   76671
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Subject) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-77907 | Film No.: 11593354
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 KING STREET WEST SCOTIA PLAZA 56TH FLOOR TORONTO A6 M5H3Y2
Business Address 40 KING STREET WEST SCOTIA PLAZA 56TH FLOOR TORONTO A6 M5H3Y2 416-366-1737
ACUITY INVESTMENT MANAGEMENT INC (Filed by) CIK: 0001424111 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G